Back
Editas Medicine Vs. Celestica Industry Stock Comparison
Sell
6
EDIT
Editas Medicine
Last Price:
$1.13
Seasonality Move:
-2.49%
Buy
52
CLS
Celestica
Last Price:
$69.12
Seasonality Move:
9.9%
Sell
6
Editas Medicine (EDIT)
is a Sell
Is Editas Medicine a Buy, Sell or Hold?
-
The current Editas Medicine [EDIT] share price is $1.12. The Score for EDIT is 6, which is 88% below its historic median score of 50, and infers higher risk than normal.
-
EDIT is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk could be especially high.
EDIT Stock Price Chart
What is Editas Medicine's stock price today?
-
The Editas Medicine share price today is $1.12The current trend is moderately bullish and EDIT is experiencing slight selling pressure.
CLS Stock Price Chart
EDIT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.31 | Buy |
Relative Strength Index (14 RSI): | 38.66 | Sell |
Chaikin Money Flow: | -911941 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.2 - 1.72) | Sell |
Bollinger Bands (100): | (1.12 - 2.3) | Sell |
CLS Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 20.94 | Buy |
Relative Strength Index (14 RSI): | 31.37 | Sell |
Chaikin Money Flow: | -6876679 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (81.03 - 97.89) | Sell |
Bollinger Bands (100): | (82.61 - 115.11) | Sell |
EDIT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.21 | Sell |
20-day SMA: | 1.36 | Sell |
50-day SMA: | 1.48 | Sell |
200-day SMA: | 2.94 | Sell |
8-day EMA: | 1.12 | Buy |
20-day EMA: | 0.82 | Buy |
50-day EMA: | 0.44 | Buy |
200-day EMA: | 0.13 | Buy |
CLS Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 82.69 | Sell |
20-day SMA: | 87.38 | Sell |
50-day SMA: | 105.52 | Sell |
200-day SMA: | 76.67 | Sell |
8-day EMA: | 75.5 | Sell |
20-day EMA: | 56.08 | Buy |
50-day EMA: | 30.47 | Buy |
200-day EMA: | 9 | Buy |
Editas Medicine Earnings Growth & EDIT Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.45 per share, a decrease next quarter of $0.02 per share, an increase this year of $1.12 per share, and an increase next year of $0.41 per share.
Celestica Earnings Growth & CLS Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.32 per share, an increase next quarter of $0.10 per share, an increase this year of $0.96 per share, and an increase next year of $1.06 per share.
Editas Medicine Technical Analysis
Mar 21 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 28 | Mar 31 | Apr 1 | Apr 2 | Apr 3 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | Apr | |||||||||
21 | 24 | 25 | 26 | 27 | 28 | 31 | 01 | 02 | 03 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Celestica Technical Analysis
Mar 21 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 28 | Mar 31 | Apr 1 | Apr 2 | Apr 3 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | Apr | |||||||||
21 | 24 | 25 | 26 | 27 | 28 | 31 | 01 | 02 | 03 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |